阿麦兰肽在皮肤病治疗中的应用

Q1 Medicine Skin therapy letter Pub Date : 2018-11-01

Morgan M McNeil, Amanda F Nahhas, Taylor L Braunberger, Iltefat H Hamzavi

{"title":"阿麦兰肽在皮肤病治疗中的应用","authors":"Morgan M McNeil, Amanda F Nahhas, Taylor L Braunberger, Iltefat H Hamzavi","doi":"","DOIUrl":null,"url":null,"abstract":"Afamelanotide, an α-melanocyte stimulating hormone analogue, has become an emerging therapeutic option for a variety of skin conditions previously refractory to other treatments. Its efficacy has been demonstrated in several dermatologic conditions, including erythropoietic protoporphyria (EPP), solar urticaria, polymorphic light eruption (PMLE), vitiligo, acne, and Hailey-Hailey disease. Its relatively low risk side effect profile makes it an attractive treatment option and also paves the way for innovative use in other disorders.","PeriodicalId":21829,"journal":{"name":"Skin therapy letter","volume":"23 6","pages":"6-10"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Afamelanotide in the Treatment of Dermatologic Disease\",\"authors\":\"Morgan M McNeil, Amanda F Nahhas, Taylor L Braunberger, Iltefat H Hamzavi\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Afamelanotide, an α-melanocyte stimulating hormone analogue, has become an emerging therapeutic option for a variety of skin conditions previously refractory to other treatments. Its efficacy has been demonstrated in several dermatologic conditions, including erythropoietic protoporphyria (EPP), solar urticaria, polymorphic light eruption (PMLE), vitiligo, acne, and Hailey-Hailey disease. Its relatively low risk side effect profile makes it an attractive treatment option and also paves the way for innovative use in other disorders.\",\"PeriodicalId\":21829,\"journal\":{\"name\":\"Skin therapy letter\",\"volume\":\"23 6\",\"pages\":\"6-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Skin therapy letter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin therapy letter","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

Afamelanotide是一种α-黑素细胞刺激激素类似物，已经成为一种新兴的治疗选择，用于治疗以前难以用其他治疗方法治疗的各种皮肤状况。其疗效已被证明在几种皮肤病，包括红细胞生成性原生卟啉症(EPP)，日光性荨麻疹，多态光疹(PMLE)，白癜风，痤疮，和黑利-黑利病。其相对较低的风险副作用使其成为一种有吸引力的治疗选择，也为其他疾病的创新应用铺平了道路。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Afamelanotide in the Treatment of Dermatologic Disease

Afamelanotide, an α-melanocyte stimulating hormone analogue, has become an emerging therapeutic option for a variety of skin conditions previously refractory to other treatments. Its efficacy has been demonstrated in several dermatologic conditions, including erythropoietic protoporphyria (EPP), solar urticaria, polymorphic light eruption (PMLE), vitiligo, acne, and Hailey-Hailey disease. Its relatively low risk side effect profile makes it an attractive treatment option and also paves the way for innovative use in other disorders.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊